These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38848204)

  • 1. Impact of lipoprotein(a) and fibrinogen on prognosis in patients with coronary artery disease: A retrospective cohort study.
    Liang D; Liang D; Liu J; Zheng Y; Huang D; Li Z; Huang X; Chen J
    Technol Health Care; 2024; 32(5):3317-3328. PubMed ID: 38848204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study.
    Zhang Y; Jin JL; Cao YX; Liu HH; Zhang HW; Guo YL; Wu NQ; Gao Y; Hua Q; Li YF; Xu RX; Cui CJ; Liu G; Dong Q; Sun J; Li JJ
    J Transl Med; 2020 Oct; 18(1):373. PubMed ID: 33004038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergetic impact of lipoprotein(a) and fibrinogen on stroke in coronary artery disease patients.
    Yang C; Zhu CG; Sui YG; Guo YL; Wu NQ; Dong Q; Xu RX; Qian J; Li JJ
    Eur J Clin Invest; 2024 Jun; 54(6):e14179. PubMed ID: 38363025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
    Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
    Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
    Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
    Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between lipoprotein(a), fibrinogen and their combination with all-cause, cardiovascular disease and cancer-related mortality: findings from the NHANES.
    Wang Z; Yan X; Fang L; Tang J; Zhang J
    BMC Public Health; 2024 Jul; 24(1):1927. PubMed ID: 39026192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease.
    Liu HH; Cao YX; Jin JL; Zhang HW; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Hong LF; Li JJ
    Heart; 2020 Aug; 106(16):1228-1235. PubMed ID: 32381650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the controversy surrounding the correlation between fibrinogen level and prognosis of coronary artery disease-The role of the subtypes of coronary artery disease.
    Peng Y; Li YM; Chai H; Zuo ZL; Wang PJ; Gui YY; Huang BT; Liao YB; Xia TL; Huang FY; Liu W; Zhang C; Pu XB; Chen SJ; Chen M; Huang DJ
    Int J Cardiol; 2016 Nov; 222():968-972. PubMed ID: 27526370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lipoprotein (a) Levels on Long-term Cardiovascular Outcomes in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.
    Gao S; Ma W; Huang S; Lin X; Yu M
    Am J Cardiol; 2021 Aug; 152():34-42. PubMed ID: 34130824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between admission plasma fibrinogen levels and mortality in Chinese patients with coronary artery disease.
    Peng Y; Wang H; Li YM; Huang BT; Huang FY; Xia TL; Chai H; Wang PJ; Liu W; Zhang C; Chen M; Huang DJ
    Sci Rep; 2016 Jul; 6():30506. PubMed ID: 27456064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study.
    Zhang Y; Jin JL; Cao YX; Zhang HW; Guo YL; Wu NQ; Zhu CG; Gao Y; Hua Q; Li YF; Xu RX; Li JJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):111. PubMed ID: 32646432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure.
    Bao K; Huang H; Huang G; Wang J; Liao Y; Pan Y; Chen W; Lu J; Yang Y; Huang Z; Chen S; Chen K; Chen L
    BMC Cardiovasc Disord; 2021 Dec; 21(1):618. PubMed ID: 34961482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries.
    Hartmann M; von Birgelen C; Mintz GS; Stoel MG; Eggebrecht H; Wieneke H; Fahy M; Neumann T; van der Palen J; Louwerenburg HW; Verhorst PM; Erbel R
    J Am Coll Cardiol; 2006 Aug; 48(3):446-52. PubMed ID: 16875967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes.
    Jin JL; Cao YX; Zhang HW; Sun D; Hua Q; Li YF; Guo YL; Wu NQ; Zhu CG; Gao Y; Dong QT; Liu HH; Dong Q; Li JJ
    Diabetes Care; 2019 Jul; 42(7):1312-1318. PubMed ID: 31076417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lipoprotein(a) with long-term mortality following coronary angiography or percutaneous coronary intervention.
    Feng Z; Li HL; Bei WJ; Guo XS; Wang K; Yi SX; Luo DM; Li XD; Chen SQ; Ran P; Chen PY; Islam SMS; Chen JY; Liu Y; Zhou YL
    Clin Cardiol; 2017 Sep; 40(9):674-678. PubMed ID: 28444976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Prognostic Value of Lipoprotein(a) in Symptomatic Patients With Nonobstructive Coronary Artery Disease.
    Xie H; Chen L; Liu H; Cui Y; Zhang Z; Cui L
    Am J Cardiol; 2017 Apr; 119(7):945-950. PubMed ID: 28139221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen is related to long-term mortality in Chinese patients with acute coronary syndrome but failed to enhance the prognostic value of the GRACE score.
    Peng Y; Xia TL; Li YM; Huang FY; Chai H; Wang PJ; Liu W; Zhang C; Pu XB; Chen SJ; Chen M; Huang DJ
    Oncotarget; 2017 Mar; 8(13):20622-20629. PubMed ID: 28177915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a).
    Solfrizzi V; Colacicco AM; D'Introno A; Capurso C; Chirico M; Frisardi V; Cacciapaglia M; Vendemiale G; Capurso A; Panza F
    Rejuvenation Res; 2009 Dec; 12(6):395-402. PubMed ID: 20014954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
    Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
    Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
    Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
    J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.